Cytokine storm

DC Fajgenbaum, CH June - New England Journal of Medicine, 2020 - Mass Medical Soc
Cytokine Storm Cytokine storm, a life-threatening disorder involving cytokine elevations and
immune-cell hyperactivation, has various causes and is characterized by constitutional …

Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes

JT England, A Abdulla, CM Biggs, AYY Lee, KA Hay… - Blood Reviews, 2021 - Elsevier
A subset of patients with severe COVID-19 develop profound inflammation and multi-organ
dysfunction consistent with a “Cytokine Storm Syndrome”(CSS). In this review we compare …

Castleman disease

A Carbone, M Borok, B Damania, A Gloghini… - Nature Reviews …, 2021 - nature.com
Castleman disease (CD), a heterogeneous group of disorders that share morphological
features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical …

Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease

T Harada, Y Kikushige, T Miyamoto, K Uno… - Nature …, 2023 - nature.com
Castleman disease (CD) is a rare lymphoproliferative disorder. Among subtypes of CD,
idiopathic multicentric CD-not otherwise specified (iMCD-NOS) has a poor prognosis and its …

mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome

Z Huang, X You, L Chen, Y Du, K Brodeur… - Nature …, 2022 - nature.com
Still's disease is a severe inflammatory syndrome characterized by fever, skin rash and
arthritis affecting children and adults. Patients with Still's disease may also develop …

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease

SK Pierson, L Katz, R Williams, M Mumau… - Nature …, 2022 - nature.com
Idiopathic multicentric Castleman disease (iMCD) is a rare and poorly-understood cytokine
storm-driven inflammatory disorder. Interleukin-6 (IL-6) is a known disease driver in some …

The role of mTOR inhibitors in hematologic disease: from bench to bedside

Y Feng, X Chen, K Cassady, Z Zou, S Yang… - Frontiers in …, 2021 - frontiersin.org
The mTOR pathway plays a central role in many cellular processes, such as cellular growth,
protein synthesis, glucose, and lipid metabolism. Aberrant regulation of mTOR is a hallmark …

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

SK Pierson, S Shenoy, AB Oromendia… - Blood …, 2021 - ashpublications.org
Idiopathic multicentric Castleman disease (iMCD) is a poorly understood hematologic
disorder involving cytokine-induced polyclonal lymphoproliferation, systemic inflammation …

Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis

Z Mao, Y Tan, J Tao, L Li, H Wang, F Yu, A Perl… - …, 2022 - academic.oup.com
Objective This study was initiated to evaluate mammalian target of rapamycin (mTOR)
activation in renal tissue of LN patients. Methods This retrospective study included 187 LN …

Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric Castleman disease

A Nishikori, MF Nishimura, Y Nishimura… - International journal of …, 2022 - mdpi.com
Idiopathic multicentric Castleman disease (iMCD) is a type of Castleman disease that is not
related to KSHV/HHV8 infection. Currently, iMCD is classified into iMCD-TAFRO …